Wolverine Trading
COGT icon

Wolverine Trading’s Cogent Biosciences COGT Stock Holding History

Wolverine Trading’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-30,000
Closed -$231K – 4879
2024
Q4 		$231K Buy
+30,000
New +$299K ﹤0.01% 4333

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Wolverine Trading's COGT Position: Q1 2025 in Review

Wolverine Trading sold out of Cogent Biosciences (COGT) in Q1 2025, closing a stake of 22,325 shares — an estimated $172K sold.

Wolverine Trading first reported a position in COGT in Q4 2024 and held it in 1 quarter. The position peaked at $172K in Q4 2024. 186 funds tracked by Wall St. Rank hold COGT as of Q1 2025.

  • Wolverine Trading reported no remaining Cogent Biosciences position as of Q1 2025 after selling out during the quarter.
  • Wolverine Trading sold 22,325 Cogent Biosciences shares in Q1 2025, an estimated $172K.
  • Wolverine Trading first reported a position in Cogent Biosciences in Q4 2024 and held it in 1 quarter.
  • Wolverine Trading's Cogent Biosciences position peaked at $172K in Q4 2024.
  • 186 funds tracked by Wall St. Rank held Cogent Biosciences as of Q1 2025.

Based on Wolverine Trading's 13F filing for Q1 2025, filed 15 May 2025.